Sneak peak at what the microbiome can do for autoimmunity. We will be holding a short course on the microbiome it’s promises during Cambridge Healthtech Institute’s 23rd International Molecular Med Tri-Con on March 6, 2016 in San Francisco – The Microbiome: Sorting the Hype from the Hope.
Joining us are the Sonnenburg Lab, the Knight Lab, Second Genome, Osel Inc., AOBiome, and Whole Biome.
Invisible Epidemic of Autoimmune Disease As we continue to illuminate the hidden costs of the long-ignored epidemic of autoimmune disease (AIID), we must shine a light on the highest autoimmune cost: Specialty pharmaceuticals. Current data
The Problem: We Don’t Really Know! The problem with estimating the total cost burden of the autoimmune disease (AIID) epidemic is that we really don’t know! A May 2022 NIH report validates our long-held belief
We have noticed much confusion among our broad digital health/virtual-first care network about the definitions of conventional, lifestyle, functional and alternative medicine. To add to the confusion, each picks and chooses techniques from the others
NIH Report Shows Why The AIID Epidemic is Invisible An NIH research report on autoimmune disease, published May, 2022, explains why, despite affecting more Americans than cancer, autoimmune and immunoinflammatory diseases (AIIDs) remain an invisible